Emerging Targets in Cancer Management: Role of the CXCL12/CXCR4 Axis

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s36109
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Role of the CXCL12/CXCR4 Axis in Peritoneal Carcinomatosis of Gastric Cancer

Cancer Research
Cancer ResearchOncology
2006English

The CXCL12-CXCR4 Chemokine Pathway: A Novel Axis Regulates Lymphangiogenesis

Clinical Cancer Research
Cancer ResearchOncology
2012English

The CXCL12/CXCR4 Axis Promotes Ligand-Independent Activation of the Androgen Receptor

Molecular and Cellular Endocrinology
BiochemistryEndocrinologyMolecular Biology
2012English

CXCR4/CXCL12 Axis in Non Small Cell Lung Cancer (NSCLC) Pathologic Roles and Therapeutic Potential

Theranostics
MedicineToxicologyPharmaceuticsPharmacology
2013English

The Importance of the CXCL12/CXCR4 Axis in Therapeutic Approaches to Diabetes Mellitus Attenuation

Frontiers in Immunology
AllergyImmunology
2015English

Inhibition of the CXCL12/CXCR4 Chemokine Axis With AMD3100, a CXCR4 Small Molecule Inhibitor, Worsens Murine Hepatic Injury

Hepatology Research
HepatologyInfectious Diseases
2014English

New Emerging Targets in Cancer Immunotherapy: The Role of Neoantigens

ESMO Open
Cancer ResearchOncology
2020English

The CXCR4-CXCL12 Axis in Ewing Sarcoma: Promotion of Tumor Growth Rather Than Metastatic Disease

Clinical Sarcoma Research
Oncology
2012English

CXCR4/CXCL12/CXCR7 Axis Is Functional in Neuroendocrine Tumors and Signals on mTOR

Oncotarget
Oncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy